Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.64 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.57 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.57 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.57 |
| ▸ | NPC1 | O15118 | 6/20 | 0.56 |
| ▸ | RAB9A | P51151 | 6/20 | 0.56 |
| ▸ | DAPK3 | O43293 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.51 |
| ▸ | GAA | P10253 | 2/20 | 0.51 |
| ▸ | HPGD | P15428 | 1/20 | 0.51 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.51 |
| ▸ | PLCG2 | P16885 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 5/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | RECQL | P46063 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.49 |
| ▸ | MEN1 | O00255 | 5/20 | 0.49 |
| ▸ | TNNI3 | P19429 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21217197 | 0.96 | SMN1; SMN2 (0.68) | SMN1; SMN2CSNK2A2CSNK2BCSNK2A1NPC1 | |
| SCHEMBL12914553 | 0.96 | SMN1; SMN2 (0.68) | SMN1; SMN2CSNK2A2CSNK2BCSNK2A1NPC1 | |
| SCHEMBL24241399 | 0.86 | NPC1 (0.69) | SMN1; SMN2CSNK2A2CSNK2BCSNK2A1NPC1 | |
| SCHEMBL24534758 | 0.85 | GAA (0.58) | SMN1; SMN2CSNK2A2CSNK2BCSNK2A1NPC1 | |
| SCHEMBL24534523 | 0.85 | NPC1 (0.61) | SMN1; SMN2CSNK2A2CSNK2BCSNK2A1NPC1 | |
| SCHEMBL24241458 | 0.85 | NPC1 (0.61) | SMN1; SMN2CSNK2A2CSNK2BCSNK2A1NPC1 | |
| SCHEMBL22505100 | 0.82 | CSNK2A2 (0.61) | SMN1; SMN2CSNK2A2CSNK2BCSNK2A1NPC1 | |
| SCHEMBL24534934 | 0.82 | CSNK2A2 (0.61) | SMN1; SMN2CSNK2A2CSNK2BCSNK2A1NPC1 | |
| SCHEMBL24241482 | 0.82 | NPC1 (0.49) | SMN1; SMN2CSNK2A2CSNK2BCSNK2A1NPC1 | |
| SCHEMBL6802454 | 0.81 | CSNK2A2 (0.81) | SMN1; SMN2CSNK2A2CSNK2BCSNK2A1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220193041-A1 | NOVEL COMPOUND AND METHOD FOR PREVENTING OR TREATING OF RESPIRATORY DISEASES COMPRISING THE SAME AS AN ACTIVE INGREDIENT | Yonsei University, University - Industry Foundation (UIF) (KR) | 2022-06-23 | — | — | US | disclosed |
| EP-3949963-A1 | NOVEL COMPOUND AND COMPOSITION FOR PREVENTION OR TREATMENT OF RESPIRATORY DISEASES COMPRISING SAME AS ACTIVE INGREDIENT | Yonsei University, University-Industry Foundation(UIF). (KR) | 2022-02-09 | — | — | EP | disclosed |
| WO-2020204602-A1 | NOVEL COMPOUND AND COMPOSITION FOR PREVENTION OR TREATMENT OF RESPIRATORY DISEASES COMPRISING SAME AS ACTIVE INGREDIENT | 연세대학교 산학협력단 | 2020-10-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220193041-A1 | NOVEL COMPOUND AND METHOD FOR PREVENTING OR TREATING OF RESPIRATORY DISEASES COMPRISING THE SAME AS AN ACTIVE INGREDIENT | EPX, CFTR, MPO | SMN1; SMN2 1363/4885CSNK2A2 2681/4885CSNK2B 2470/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.